Oncogene - Table of Contents alert Volume 36 Issue 35

If you are unable to see the message below, click here to view.

Advertisement New publication: Best practices for low input ChIP-seq ChIP-seq has become the gold standard to investigate genome-wide epigenetic profiles.  However, ChIP from limited cell inputs has been challenging.  Diagenode and Advanced Analytical Technologies, Inc. (AATI) provide first complete and robust workflow solution for ChIP-seq from very small numbers of cells using critical quality checkpoints to assure success. Read the new publication. TABLE OF CONTENTS Volume 36, Issue 35 (August 2017) In this issue Original Articles Short Communications Corrigendum Errata Also new AOP   Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Celebrating 30 years of Oncogene — 1987 to 2017 Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone.  Watch our anniversary video showing a brief impact overview >>>   Original Articles Top Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins A Antignani, D Segal, N Simon, R J Kreitman, D Huang and D J FitzGerald Oncogene 2017 36: 4953-4962; advance online publication, April 24, 2017; 10.1038/onc.2017.111 Abstract | Full Text Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells E Raja, A Komuro, R Tanabe, S Sakai, Y Ino, N Saito, T Todo, M Morikawa, H Aburatani, D Koinuma, C Iwata and K Miyazono Oncogene 2017 36: 4963-4974; advance online publication, May 1, 2017; 10.1038/onc.2017.112 Abstract | Full Text Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer M Pek, S M J M Yatim, Y Chen, J Li, M Gong, X Jiang, F Zhang, J Zheng, X Wu and Q Yu Oncogene 2017 36: 4975-4986; advance online publication, May 1, 2017; 10.1038/onc.2017.120 Abstract | Full Text Insulin resistance in vascular endothelial cells promotes intestinal tumour formation X Wang, M-F Häring, T Rathjen, S M Lockhart, D Sørensen, S Ussar, L M Rasmussen, M M Bertagnolli, C R Kahn and C Rask-Madsen Oncogene 2017 36: 4987-4996; advance online publication, May 1, 2017; 10.1038/onc.2017.107 Abstract | Full Text INTU is essential for oncogenic Hh signaling through regulating primary cilia formation in basal cell carcinoma N Yang, E L-H Leung, C Liu, L Li, T Eguether, X-J Jun Yao, E C Jones, D A Norris, A Liu, R A Clark, D R Roop, G J Pazour, K R Shroyer and J Chen Oncogene 2017 36: 4997-5005; advance online publication, May 1, 2017; 10.1038/onc.2017.117 Abstract | Full Text MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma Y-S Liu, H-Y Lin, S-W Lai, C-Y Huang, B-R Huang, P-Y Chen, K-C Wei and D-Y Lu Oncogene 2017 36: 5006-5022; advance online publication, May 1, 2017; 10.1038/onc.2017.129 Abstract | Full Text MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells J Zhao, Y Wang, C Mu, Y Xu and J Sang Oncogene 2017 36: 5023-5034; advance online publication, May 1, 2017; 10.1038/onc.2017.131 Abstract | Full Text Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia M P Hanley, M A Hahn, A X Li, X Wu, J Lin, J Wang, A H Choi, Z Ouyang, Y Fong, G P Pfeifer, T J Devers and D W Rosenberg Oncogene 2017 36: 5035-5044; advance online publication, May 1, 2017; 10.1038/onc.2017.130 Abstract | Full Text CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis OPEN X W Chen, T J Yu, J Zhang, Y Li, H L Chen, G F Yang, W Yu, Y Z Liu, X X Liu, C F Duan, H L Tang, M Qiu, C L Wang, H Zheng, J Yue, A M Guo and J Yang Oncogene 2017 36: 5045-5057; advance online publication, May 8, 2017; 10.1038/onc.2017.118 Abstract | Full Text Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis N Giebeler, A Schönefuß, J Landsberg, T Tüting, C Mauch and P Zigrino Oncogene 2017 36: 5058-5067; advance online publication, May 29, 2017; 10.1038/onc.2017.162 Abstract | Full Text Short Communications Top Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma L Dai, Z Lin, J Qiao, Y Chen, E K Flemington and Z Qin Oncogene 2017 36: 5068-5074; advance online publication, May 1, 2017; 10.1038/onc.2017.122 Abstract | Full Text MYCN induces neuroblastoma in primary neural crest cells OPEN R R Olsen, J H Otero, J García-López, K Wallace, D Finkelstein, J E Rehg, Z Yin, Y-D Wang and K W Freeman Oncogene 2017 36: 5075-5082; advance online publication, May 1, 2017; 10.1038/onc.2017.128 Abstract | Full Text Corrigendum Top RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma OPEN T Sakurai, K Isogaya, S Sakai, M Morikawa, Y Morishita, S Ehata, K Miyazono and D Koinuma Oncogene 2017 36: 5083; advance online publication, June 12, 2017; 10.1038/onc.2017.191 Full Text Errata Top A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion G Agaësse, L Barbollat-Boutrand, E Sulpice, R Bhajun, M El Kharbili, O Berthier-Vergnes, F Degoul, A de la Fouchardière, E Berger, T Voeltzel, J Lamartine, X Gidrol and I Masse Oncogene 2017 36: 5084; advance online publication, June 19, 2017; 10.1038/onc.2017.195 Full Text Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions OPEN J Zámborszky, B Szikriszt, J Z Gervai, O Pipek, Á Póti, M Krzystanek, D Ribli, J M Szalai-Gindl, I Csabai, Z Szallasi, C Swanton, A L Richardson and D Szüts Oncogene 2017 36: 5085-5086; advance online publication, June 26, 2017; 10.1038/onc.2017.213 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.